Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Eli Lilly and Company

    World Rank (Jan-05-2024)
    10
    Market Cap (Jan-05-2024)
    586.387 Billion USD
    World Rank (Jul-30-2023)
    16
    Market Cap (Jul-30-2023)
    435.220 Billion USD
    World Rank (Dec-25-2022)
    19
    Market Cap (Dec-25-2022)
    349.570 Billion USD
    World Rank (Jan-07-2022)
    39
    Market Cap (Jan-07-2022)
    248.24 Billion USD
    Annual Revenue in USD
    34,124 Million USD
    Annual Operating Income in USD
    10,787 Million USD
    Annual Net Income in USD
    5,240 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

    As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

    Facts About Eli Lilly as on 2022:

    Facts About Company

    As on 2022, Eli Lilly has 39,000 employees.

    Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

    Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

    Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

    Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

  2. Unitedhealth Group

    World Rank (Jan-05-2024)
    12
    Market Cap (Jan-05-2024)
    504.473 Billion USD
    World Rank (Jul-30-2023)
    12
    Market Cap (Jul-30-2023)
    468.230 Billion USD
    World Rank (Dec-25-2022)
    7
    Market Cap (Dec-25-2022)
    496.430 Billion USD
    World Rank (Jan-07-2022)
    16
    Market Cap (Jan-07-2022)
    431.93 Billion USD
    Annual Revenue in USD
    322,130 Million USD
    Annual Operating Income in USD
    26,400 Million USD
    Annual Net Income in USD
    20,120 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    UnitedHealth Group is a health and well-being company headquartered in the United States, and helping people live healthier lives and helping make the health system work better for everyone. Headquarters is in USA.

    Facts About Company
    • UnitedHealth Group annual revenue generated for period ending Dec-2022 was 322.13 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2022 was 20.12 Billion USD.
    • UnitedHealth Group annual revenue generated for period ending Dec-2021 was 285.27 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2021 was 17.28 Billion USD.
  3. Novo Nordisk A/S

    World Rank (Jan-05-2024)
    16
    Market Cap (Jan-05-2024)
    459.394 Billion USD
    World Rank (Jul-30-2023)
    24
    Market Cap (Jul-30-2023)
    356.920 Billion USD
    World Rank (Dec-25-2022)
    27
    Market Cap (Dec-25-2022)
    301.520 Billion USD
    World Rank (Jan-07-2022)
    50
    Market Cap (Jan-07-2022)
    231.35 Billion USD
    Annual Revenue in USD
    26,157 Million USD
    Annual Operating Income in USD
    11,058 Million USD
    Annual Net Income in USD
    8,208 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

    Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

    Facts About Company

    For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

    For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

  4. Johnson & Johnson

    World Rank (Jan-05-2024)
    21
    Market Cap (Jan-05-2024)
    387.499 Billion USD
    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.430 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.94 Billion USD
    Annual Revenue in USD
    94,940 Million USD
    Annual Operating Income in USD
    23,700 Million USD
    Annual Net Income in USD
    17,940 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

    Facts About Company
    • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
    • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

    Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

  5. Merck & Co

    World Rank (Jan-05-2024)
    28
    Market Cap (Jan-05-2024)
    296.506 Billion USD
    World Rank (Jul-30-2023)
    32
    Market Cap (Jul-30-2023)
    269.830 Billion USD
    World Rank (Dec-25-2022)
    30
    Market Cap (Dec-25-2022)
    283.610 Billion USD
    World Rank (Jan-07-2022)
    59
    Market Cap (Jan-07-2022)
    202.83 Billion USD
    Annual Revenue in USD
    59,280 Million USD
    Annual Operating Income in USD
    18,280 Million USD
    Annual Net Income in USD
    14,510 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company manufacture and sells innovative medicines, vaccines, and animal health products. Headquarters is in USA.

    Merck & Co focus on scientific innovation to deliver medicines and vaccines.

    Facts About Company

    As on 2022, Merck & Co has 69,000 employees.

    For year ending Dec-2022, Merck & Co annual revenue was 59.28 billion USD and annual net income was 14.51 billion USD.

    For year ending Dec-2021, Merck & Co annual revenue was 48.70 million USD and annual net income was 13.04 million USD.

    Total Assets as on Dec-2022 was 109,160 Million USD.

  6. Abbvie

    World Rank (Jan-05-2024)
    32
    Market Cap (Jan-05-2024)
    285.064 Billion USD
    World Rank (Jul-30-2023)
    33
    Market Cap (Jul-30-2023)
    266.140 Billion USD
    World Rank (Dec-25-2022)
    29
    Market Cap (Dec-25-2022)
    288.440 Billion USD
    World Rank (Jan-07-2022)
    46
    Market Cap (Jan-07-2022)
    238.45 Billion USD
    Annual Revenue in USD
    58,054 Million USD
    Annual Operating Income in USD
    18,814 Million USD
    Annual Net Income in USD
    11,782 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

    Facts About Company

    As on 2023, Abbvie has 50,000 employees.

    Abbvie annual revenue generated for period ending Dec-2022 was 58,054 million USD.

    Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

    Abbvie annual revenue generated for period ending Dec-2021 was 56,197 million USD.

    Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

    Total Assets as on Dec-2022 was 138,805 Million USD.

  7. Roche Holding AG

    World Rank (Jan-05-2024)
    40
    Market Cap (Jan-05-2024)
    238.453 Billion USD
    World Rank (Jul-30-2023)
    38
    Market Cap (Jul-30-2023)
    249.730 Billion USD
    World Rank (Dec-25-2022)
    32
    Market Cap (Dec-25-2022)
    261.410 Billion USD
    World Rank (Jan-07-2022)
    25
    Market Cap (Jan-07-2022)
    356.15 Billion USD
    Annual Revenue in USD
    72,691 Million USD
    Annual Operating Income in USD
    20,068 Million USD
    Annual Net Income in USD
    14,267 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Roche Holding is  Healthcare Company having business in pharmaceuticals and diagnostics. The headquarters is in Switzerland. 

    Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Ophthalmology and Respiratory branches Medicines.

    Facts About Company

    Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

    Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

    As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

  8. Novartis AG

    World Rank (Jan-05-2024)
    45
    Market Cap (Jan-05-2024)
    216.513 Billion USD
    World Rank (Jul-30-2023)
    45
    Market Cap (Jul-30-2023)
    220.820 Billion USD
    World Rank (Dec-25-2022)
    47
    Market Cap (Dec-25-2022)
    195.460 Billion USD
    World Rank (Jan-07-2022)
    61
    Market Cap (Jan-07-2022)
    201.26 Billion USD
    Annual Revenue in USD
    51,830 Million USD
    Annual Operating Income in USD
    9,190 Million USD
    Annual Net Income in USD
    6,950 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

    Facts About Company

    Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

    Novartis had over 101,703 employees worldwide as on 2022.

    Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

  9. AstraZeneca

    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    44,351 Million USD
    Annual Operating Income in USD
    4,561 Million USD
    Annual Net Income in USD
    3,288 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, Astrazeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.

    AstraZeneca Product Sales split by Disease Area for year ending Dec-2021

    Facts About Company

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.

    AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.

    AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.

    AstraZeneca Product Sales split of 44,351 Million USD by Disease Area for year ending Dec-2022

  10. Thermo Fisher Scientific

    World Rank (Jan-05-2024)
    52
    Market Cap (Jan-05-2024)
    207.621 Billion USD
    World Rank (Jul-30-2023)
    48
    Market Cap (Jul-30-2023)
    216.720 Billion USD
    World Rank (Dec-25-2022)
    39
    Market Cap (Dec-25-2022)
    212.050 Billion USD
    World Rank (Jan-07-2022)
    45
    Market Cap (Jan-07-2022)
    239.22 Billion USD
    Annual Revenue in USD
    44,915 Million USD
    Annual Operating Income in USD
    8,507 Million USD
    Annual Net Income in USD
    6,950 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Thermo Fisher Scientific is USA Based Bio-Technology and Healthcare Company. Develops and manufactures Medical Equipment. Headquarters is in USA.

    Facts About Company

    As on 2022, Thermo Fisher Scientific has 130,000 employees.

    Thermo Fisher Scientific annual revenue generated for period ending Dec-2022 was 44,915 million USD.

    Thermo Fisher Scientific annual net income generated for period ending Dec-2022 was 6,950 million USD.

    For Year ending December-2021, Thermo Fisher Scientific annual revenues was 39,211 Million USD and Net Income was 7,725 Million USD.

    As of December-2020, they had 80,000 employees.

Share

Ads